|
Vessel and hollow organ radiation device In the presented device comprising a laser and a fibre-optic cable including an optic connector, a light guide with an optic core, an optic jacket and a protective polymeric jacket, an elongated diffuser with an optic core and an optic jacket, accommodating series an operational area, an optical area and a distal cone at the end, a protective cap made of an optically transparent inert material and having a cylindrical surface attached to the optic jacket in the operational area of the diffuser, and a heat-shrink protective tube on adjoining sections of the protective polymeric jacket of the light guide and the protective cap of the diffuser, covering the operational area of the diffuser. The surface of the optical area of the diffuser bears a spiral slot with a pitch distance not less than its width and no more than 1/2 lengths of the optical area of the diffuser. The slot depth smoothly increases towards the distal cone. The diffuser has a constant diameter in the operational area and an opening section of the optical area of the diffuser, a length of which makes at least 1/2 and no more than 3/4 of the length of the optical area of the diffuser, whereas in the other section of the optical area, the diffuser diameter monotonically decreases towards the distal cone. The distal cone diameter is equal to the lesser diameter of the diffuser; a conical surface of the distal cone has an angle ranging within (38÷45)° in relation to the optical axis. |
|
|
Method of treating patients with pleural effusion of various aetiology Invention refers to medicine, namely pulmonology, phthisiology and thoracic surgery, and may be used for treating patients with pleural effusion of various aetiology. That is ensured by a standard drug therapy, effusion aspiration from a pleural cavity and complex use of medicinal preparations and laser exposure. That involves conducting a combination laser therapy by means of Matrix-VLOK apparatus with intrapleural and intravenous laser exposure alternated every second day. The exposure is conducted at wavelength 0.365 mcm at disposable end-face output power 1-1.5 mW and pulse frequency 80 Hz in the continuous radiation mode for 10 minutes. After the effusion is aspirated from the pleural cavity, cefazolin 1.0 g is introduced therein. The therapeutic course makes from 3 to 7 procedures. |
|
Method of treating patients with nodular and radioresistant malignant tumours Photosensitiser Photosens in a dose in 0.3-0.4 mg/kg is administered into the patient once. A first session of a gamma-ray teletherapy covering the tumour is performed 24 hours later in a single boost dose of 3 Gy. A first session of a remote exposure of the tumour and surrounding healthy tissues to laser light at wave length 670 nm is performed 2-3 hours later in a single light dose Ws of 50-100 J/cm2 at power density Ps 40-50 mW/cm2. That is combined with a session of a contact direct exposure of the tumour to laser light at wave length 670 nm from 2-5 positions depending on a tumour size at a light guide output power P of 100-200 mW and a light dose W of 100 J per each position. The treatment involve 8-10 sessions of the combined gamma-ray teletherapy and photodynamic therapy every 24 hours in the same sequence. That is followed by the gamma-ray teletherapy during 2-4 days. |
|
|
Method of treating periodontitis with use of lamifaren gel Invention concerns a method of treating inflammatory periodontal diseases involving administering Lamifaren therapeutic gel in an amount of 0.2-0.3 g into each gingival pocket of upper and lower jaws by means of a syringe with a blunt needle. With the gel left inside, 15 minutes later, the pockets are exposed by means of a point head at emission power 0.4 W, power density 18-20 J/cm2, for 15-30 seconds each. After each procedure, the gingival surface with the residual gel is coated with Septopack therapeutic dressing for 4 hours. The therapeutic course involves 4 daily procedures: 2 procedures alternated for the upper and lower jaws. Lamifaren is also prescribed orally 20-30 minutes before a meal in a dose of 60 g 3 times a day during 30 days. |
|
Method of treating patients with ischemic heart disease What is used is a complex of three physical body exposures. That is ensured by an artificial circulatory support enabled by an enhanced external counterpulsation apparatus with a cuff pressure of 220 mm Hg as a one-hour session, once a day; the therapeutic course is 14-15 sessions. Herewith, during 10 sessions, one hour after the external counterpulsation, the patient takes carbon dioxide baths in the Reabox system at a carbon dioxide flow rate of 12 l/min, a gas mixture temperature of 36-37°C for 10-15 minutes. An infrared laser therapy is conducted 30 minutes after the bath, by using the Mustang 2000+ apparatus according to a stable technique with a 5 W emitter covering the apex of the heart, a middle one-third of the sternum, the left infrascapular region, 2-3 min. each. The laser therapy course includes 10 daily procedures. |
|
|
Method of treating periodontitis with using kanalgat gel One stage involves administering anti-inflammatory gel into gingival pockets and conducting laser-phoresis within an area of the preparation administration. The above gel is Kanalgat dissolved in distilled water in ratio 3:1. The gel is additionally applied over a gingival margin with covering a dental surface. The laser-phoresis has the following parameters: transmission power 0.4 Wt, energy density 18-20 J/cm2, and wave length 662 nm. The exposure is performed through a gingival margin and covers upper and lower jaws in segments: 1.8-1.3; 1.3-2.3; 2.3-2.8 for the upper jaw segments and 3.8-3.3; 3.3-4.3; 4.3-4.8 for the lower jaw segments. The exposure length makes 4 minutes per each segment: 2 minutes from a vestibular side and 2 minutes from a palatal (tongue) side. After the gel is removed, a dressing of Solcoseryl dental adhesive paste is applied. The therapeutic course makes 6 daily procedures. |
|
Method of treating periodontal diseases Involved sites are coated with Geleophor Photosensitiser Gel. The gel is washed away then, and the sites are exposed to laser light. The exposure additionally covers preauricular, mandibular and submental lymph nodes from both sides for 2-3 min per each field; the therapeutic course is 3-4 procedures. That is followed by an electric stimulation with bipolar pulse currents covering an orbicular muscle of mouth and anterior bellies of the digastric muscle. The exposure also covers a superior thoracic spine within a trapezius muscle. A current intensity is 5-20 mA; a pulse train and interpulse time are of 2 s each; an exposure length is 10-20 min; the therapeutic course is 8-12 procedures either daily, or every second day, depending on the patient's state. |
|
|
Method for laser phoresis in treating chronic rhinosinusitis polyposa Laser interstitial thermal therapy (LITT) with high-energy laser light irradiation of polyp tissue is followed by infiltration administration of 1% emoxypine in an amount of up to 1.0 ml into a polyp stroma. A distal end of a light guide of a helium neon laser at wave length 0.63 mcm is delivered to the polyp. A maximum output power of the laser light is 40 mW. A power flow density is 35-60 mW/cm2. A light spot diameter is 2 cm. A single radiation dose is from 3.5 to 5.5 J/cm2. The polyp is exposed for 5 minutes daily during 7 days. |
|
Affected areas are exposed to narrow-band medium-wave ultraviolet light at wave length 311 nm. That is combined with applications of VITISKIN gel applied on depigmentations 1 hour before the exposure. The therapeutic course makes 10-12 procedures. |
|
Method for face and neck skin structure recovery Method involves skin peel and ozone vaporisation. The face and neck are covered with an application photosensitiser. A session of the face and neck skin photodynamic radiation (PDR) is performed 30 or 40 minutes later. A 15-30-minute soothing mask is applied. A PDR session is preceded by hydrocolonotherapy during 1 week. A liver cleanse is performed one day after the first session of hydrocolonotherapy. Twenty-four hours after the hydrocolonotherapy is completed, the first of 8 sessions of the laser acupuncture of the face and neck biologically active points is performed with each point continuously exposed for 25 s to the red laser light. The exposure wave length is 630 nm; power is 1 mW. Before the application photosensitiser is applied, the face and neck epidermis are additionally activated by the 10-minute exposure to the blue laser light at a wave length of 417 nm. Power density is 50 mW/cm2; specific exposure dose is 7.5 J/cm2. Every face and neck skin PDR session is 40 min long and involves the exposure to the red laser light at a wave length of 662 nm, power density of 150 mW/cm2 and specific exposure dose of 27-32 J/cm2. The first PDR session is performed 48 hours after the first session of the laser puncture of the biologically active points. Each following PDR session is performed two weeks after the previous one. |
|
Method of treating patients suffering from community-acquired pneumonia Prescribing a complex of medicinal products is combined with exposing the patient's blood intravenously to a continuous laser light generated by the Matrix-VLOK apparatus. The medicinal products involve antibacterial and mucolytic preparations; a detoxification therapy is also conducted. If observing a moderate clinical course of community-acquired pneumonia in a combination with lactoferrin measured at 2,420 ng/ml and 34% spontaneous and 55% stimulated nitro blue tetrazolium test results, 7 procedures of the 5-minute intravenous laser exposure of the patient's blood are required. A laser light wavelength is 0.405 mcm; an output power at an end face of a disposable intravenous light guide is 1.0 mW. |
|
|
Method for combined exposure to multi-frequency laser exposures Invention refers to medical equipment. A method is applicable to increase the efficacy of therapeutic and biological exposure to low-intensity laser light and provides the combined exposure of the same area of a biological object to a set of several multi-frequency laser lights. The method is based on summing the laser lights with no light guides used. Matching and summing the lights emitted by each laser light source is conducted by directing these lights in the pre-set direction onto an optical element characterised by transmitting one light almost completely and reflecting the other one almost completely. |
|
Method of treating chronic endometritis What is applied is small pelvis organs are exposed by means of the KAP-ELM-01 Andro-Gin apparatus. The treatment is two-staged. The first stage involves a physiotherapeutic provocation pre-exposure consisting of 3-5 procedures. That is combined with intracavitary electric stimulation in operation mode "3" with positive polarity, amplitude from 5% to 100% at a frequency of 50 Hz with an excitation period of 2 sec and a pause of 1 sec; neurostimulation is conducted with using a surface sensor at a frequency of 30 Hz; magnetic and laser therapies represent external and internal in-phase exposures; colour and rhythm therapy is a continuous exposure to blue and red lights with the switch position set to "3" to select power options; a switch setting period is 3 seconds at a modulation frequency of 20 Hz. The procedure length is from 15 to 20 minutes either daily or every second day. A pharmaceutical treatment is prescribed individually in accordance with reference data. The second stage represents 15-20 procedures of a primary physiotherapeutic exposure. That is combined with intracavitary electric stimulation in operation mode "4" with positive polarity, amplitude from 5% to 100% at a frequency of 80 Hz with an excitation period of 3 sec and a pause of 5 sec; neurostimulation is conducted at a frequency of 10 Hz; magnetic and laser therapies represent external and internal in-phase exposures; colour and rhythm therapy is a continuous exposure to green and orange lights with the switch position set to "3" to select power options; a switch setting period is 3 seconds at a modulation frequency of 20 Hz. Each procedure lasts for 15 to 20 minutes either daily or every second day. |
|
|
New graft is formed by FemtoLASIK technique at a depth, which is 20 mcm less than that of an incompletely formed graft in the corneal area and 1 mm less in diameter than that of the incompletely formed graft; the grafts have a common centre. The newly formed graft is separated after pre-separation of an edge of this graft starting from a graft pedicle and extending sequentially along the whole circular length; the graft itself is separated by means of a micro spatula curved along a corneal curvature. The spatula is brought along the pedicle full-length and pushed to an opposite side by rocking motions. After separation, the graft is elevated, and a stromal bed is ablated; this involves using ablation algorithm normograms to provide a refraction effect combined with removing the residual incomplete graft in depth. |
|
Method involves a combination of therapeutic-preventive measures involving drainage of an upper urinary tract by a percutaneous puncture nephrostomy, an antibiotic prevention, a physiotherapeutic exposure and 10 intramuscular injections of Longidase 3,000 International Units once every three days. On the following day after a drain tube is inserted, the course of an external magnetic-laser therapy consisting of 10 procedures starts. On the 7th day following the nephrostomic drain tube insertion, the course of a multi-channel electric stimulation (ME) with bipolar pulse currents with trapezoidal envelope frequency 1-150 Hz, pulse train and pause 2 sec. The exposure covers trapezius and broadest muscle of back, rectus and oblique abdominal muscles. The exposure length is 15-20 minutes. The ME is combined with ultraphonophoresis of Longidase 3,000 IU in a projection of the involved ureter at intensity 0.2 Wt/cm2 in the continuous mode unstably. The therapeutic course makes 10-12 combined daily procedures. On completion of all the physiotherapeutic procedures, the nephrostomic drain tube is clipped. The drain tube is first clipped for 2 hours a day during 3 days, then for 6 hours during 3 days. Then if an amount of residual urine does not exceed 30 ml, the drain tube is clipped for 24 hours during 3 days. If observing no complications, the nephrostoma is removed. |
|
|
Amoxiclav is inserted in a single dose of 1.2 g 15 minutes before skin incision. During the first five postoperative days, blood is intravenously exposed to the laser light generated by the Solaris apparatus with the helium-neon light for 15 minutes daily. The wave length of the exposure is 0.63 nm; output radiation power is 1.5 mW. |
|
Method for prevention of developing radiation reactions in patients with cervical cancer 1-3 hours upon completion of every radiation treatment session, the organs and tissues covered by a radiation injury area are exposed. The exposure represents a session of a magnetic laser therapy at an emission power of 9-12 mW, a frequency of 600 Hz, a wave length of 0.85-0.89 mcm and a magnetic induction of 35 mT. A therapeutic terminal unit of a magnetic laser therapeutic apparatus is placed series onto the skin of the anterior abdominal wall in the following projections: enteric loops, the ascending colon, the transverse colon, the duodenum and the stomach, the descending colon, the sigmoid colon, the urinary bladder. The exposure length is 240 seconds per each area. |
|
|
Method for laser therapy of patients with atopic dermatitis Method involves intravenous laser blood irradiation (ILBI) at a power of 1-2 mW. The ILBI uses low-intensity continuous laser light at alternating wave lengths 365-405 nm (UVA spectrum) and 520-525 nm (green spectrum) with varying exposure during 12 daily sessions. The exposure conforms to the following schedule: 1st session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 2nd session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 3rd session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 4th session - 520-525 nm, power 1-2 mW, exposure 7 minutes; 5th session - 365-405 nm, power 1-2 mW, exposure 3 minutes; 6th session - 520-525 nm, power 1-2 mW, exposure 10 minutes; 7th session - 365-405 nm, power 1-2 mW, exposure 3 minutes; 8th session - 520-525 nm, power 1-2 mW, exposure 10 minutes; 9th session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 10th session - 520-525 nm, power 1-2 mW, exposure 7 minutes; 11th session - 365-405 nm, power 1-2 mW, exposure 2 minutes; 12th session - 520-525 nm, power 1-2 mW, exposure 5 minutes. |
|
Method of laser therapy of patients with psoriasis Method involves a session combining local laser irradiation covering 4 affected areas and intravenous laser blood irradiation (ILBI). The sessions are daily, during afternoon, during 15 days. The local exposure uses a matrix emitter consisting of 8 laser diodes of the total surface area of 8 cm2. A wave length is 635 nm. The exposure length is 2 minutes per one area in the pulse contact mode. A light pulse length is 100-130 ns. A pulse power is 40 W at a varying frequency. The ILBI uses continuous laser light at a wave length of 525 nm with varying power and exposure. The exposure conforms to the following schedule: 1st session - local: frequency 80 Hz, ILBI: power 2 mW, exposure 5 min. 2nd session - local: frequency 150 Hz, ILBI: power 5 mW, exposure 7 min. 3rd session - local: frequency 600 Hz, ILBI: power 5 mW, exposure 12 min. 4th session - local: frequency 1,500 Hz, ILBI: power 10 mW, exposure 15 min. 5th session - local: frequency 3,000 Hz, ILBI: power 15 mW, exposure 15 min. 6th-7th sessions - local: frequency 6,000 Hz, ILBI: power 15 mW, exposure 20 min. 8th-10th sessions - local: frequency 10,000 Hz, ILBI: power 20 mW, exposure 20 min. 11th-12th sessions - local: frequency 1,500 Hz, ILBI: power 20 mW, exposure 20 min. 13th-15th sessions - local: frequency 80 Hz, ILBI: power 20 mW, exposure 20 min. |
|
Method of treating patients with periodontitis Invention relates to medicine, namely to dentistry, and can be applied for treatment of periodontitis in patients. For this purpose, first, removal of supra- and subgingival dental plagues is performed by ultrasonic apparatus "PerioScan" simultaneously with antiseptic processing with solution "Octenisept" in dilution 1:10. Polishing of teeth by sand-blast apparatus "AirnGo" is carried out, with application of glycine-based powder. Teeth polishing and removal of supra- and subgingival dental plagues are carried out one timebefore carrying out first procedure of photodynamic therapy (PDT). After that, 1%. gel Radodent for carrying out of PDT is introduced into 5 or more mm deep periodontal recesses on their entire length. Laser impact is realised by diode laser in pulse mode at wavelength 662 nm, power - 0.3 W, energy density - 75 J/cm2. Light guide is submerged for the entire depth of periodontal recesses. Impact is carried out for not more than 2 minutes per one area of inflammation. The total time of procedure constitutes 14-30 minutes. Treatment course includes 3 procedures, carried out every second day. On days between PDT procedures processing of gingival with gel with bactriophages "Phagodent" is carried out twice per day with 8-10 minutes gel exposure. After finishing PDT procedures phage therapy is continued for 5-7 days. |
|
Method for detecting and localising glial brain tumours intraoperatively Invention refers to medicine, namely to neurosurgical oncology, and can be used to detect and localise a brain tumour. A surgical intervention involves taking solution of 5-aminolevilinic acid. The tumour is removed under visual control with the use of a surgical microscope provided with a white-light source. To detect the involved brain regions, a brain region of interest is occasionally illuminated locally with laser light at wave length 405 nm. The involved region is examined simultaneously in the reflected white light and protoporphyrin IX red fluorescent light through a rejection filter lens blocking the laser light reflected from the object. Using a laser emitter at wave length in the proximity of a short-wavelength visual reception limit enables blocking the reflected laser light without loss of the white light examination. |
|
Method for surgical management of thrombosis of central retinal vein and its branches Method involves sclera puncture in one of external oblique meridians of an eyeball, epiretinal administration of Gemasa 500 international units as close to an occlusion point as possible and retinal laser coagulation in the postoperative period at power 300-400 mW, exposure time 0.1-0.2 s. Immediately before the enzymatic preparation is introduced, the involved vein is massaged with a hooked end of an injection needle by performing 5-7 motions along the involved vascular stem from a distal to proximal end for 20-30 s. The contact-free retinal laser coagulation follows 2 or 3 days later. Thrombosis of the central retinal vein first requires a macular barrage in the form of a horseshoe open to an optic disk; the coagulates are applied at min. 2550-2600 mcm from a fovea; a spot diameter is 50 mcm in the single flash mode in the number of 20-25 applications; the laser is then taken to an automatic operation; and the other retinal segments are coagulated in the staggered order, thereby increasing a spot diameter up to 80-100 mcm, except for a papillomacular bundle; about 400-450 applications are used in a back pole. Treating retinal vein occlusion is ensured by paravasal laser coagulation; the laser coagulates 80-100 mcm in diameter are applied along the involved branch of the central retinal vein at min. 1600 mcm from each other in the number of 100-140 applications. |
|
Method of treating postinjection infiltrates in oncology patients From the first day a postinjection infiltrate has been found or at a later point in time, the infiltrate is exposed to infrared laser light in a constant magnetic field. The magnetic field strength falls within the range of 20-50 mT; an infrared laser pulse repetition frequency ranges within 80 Hz, whereas a transmission power is 0.25-0.5 W. The infiltrate is exposed to a defocused laser beam in the contact labile or distant labile mode at 0.3 cm for 15-25 seconds. Thereafter, tissues wetted in a hypertonic solution are applied 1-3 times a day. The therapeutic course makes 5-8 daily procedures. |
|
|
Systems and methods for stimulation of neuronal activity Group of inventions relate to medicine and medical equipment, namely to objects for nervous system stimulation. Light source is positioned in nasal cavity proximally to nerve cell. Light pulses are generated by source in order to stimulate nerve cell for specified period of time for treatment of, at least, one patient's condition. method is realised by means of system, which contains light source, made with possibility of placement in nasal cavity; controller, connected with light source, made with possibility of controlling light source operation. Controller is made with possibility of generating light pulses from light source to stimulate nerve cell for specified time period to provide treatment of, at least, one condition. |
|
Device for endoluminal treatment of blood vessel Device for the endoluminal treatment of a blood vessel comprises a flexible wave guide with a light guide tube. The wave guide has an elongated axis, a proximal end with a connector for optical connection to a laser light source, a distal end placed in the blood vessel and comprising an emitting surface for the emission of light from the light source sideways in relation to the elongated axis of the wave guide onto a surrounding vascular wall segment extending within the angular range. The device is provided with a secondary laser light source, a reflected light reception detector, a laser light transparent cone-shaped primary diffuser (1) with laser light deflection and a secondary diffuser (3) extending the laser light coverage area. The primary diffuser (1) is mounted at an optical output of the wave guide between the emitting surface of the wave guide and a sapphire safety cap (2). The secondary diffuser (3) is mounted between the safety cap (2) and the primary diffuser (1). The device also comprises a detachable sterilised protective sheath (4). The protective sheath (4) is made from heat-shrinkage polytetrafluoroethylene, configured as a tube with an ultrasound contrast insert and mounted on the wave guide over the safety cap (2). |
|
Method of deep caries treatment Opening of a carious cavity, ablation of overhanging enamel edges on the entire circumference, necrectomy and drug treatment with a 0.06% chlorhexidine solution are performed. The preparation "Lemifaren" is applied on walls and bottom of the carious cavity in a uniform 1 mm thick layer, which is left for 1 day under temporary filling. After the removal of the preparation irradiation in a pulse mode with the power of 5 W and frequency of 2000-3000 Hz is carried out for 5 min with the application of the laser apparatus ALST-01. After that, the cavity is restored with an account of functional and aesthetic parameters of the particular tooth. |
|
|
Method for endoscopic treatment of non-muscle invasive bladder cancer Transurethral bladder resection enables the exposure of tumour bed tissues to pulse laser light of wave length 970 nm and emitting power from 10 to 15 Wt. The exposure involves contacting a light guide to bladder wall wound tissues until visualising the coagulation changed within the contact exposure. That is combined with advancing the light guide spirally from the wound periphery to the tumour bed centre. A method involves improving the therapeutic effect by preventing the tumour recurrences, preventing erythrocyturia and developing complications caused by intraoperative complications, as well as preventing complications caused by the deep thermal exposure on the bladder wall. |
|
|
Method of treating patients suffering from rheumatoid arthritis Invention refers to medicine, namely to rheumatology, and can be used in treating patients suffering from rheumatoid arthritis. The method involves prescribing methotrexat 15 mg a week per os, folic acid 5 mg a week per os, movalis 15 mg a day per os. If the patient has the second degree of activity of rheumatoid arthritis, IL-1β of 1.3±0.3 pg/ml and more, IL-6 of 1.5±0.3 pg/ml and more, TNF-α of 1.78±0.35 pg/ml and more, IL-4 of 3.7±0.34 pg/ml and less, leptine of 6.4±0.42 pg/ml and more, glycosaminoglycans of 0.310±0.032 g/l, 7 daily procedures of intravenous laser exposure are prescribed. The KL-VLOK radiation head with a wavelength of 635 nm, disposable light guide tip power of 1.5 mW, exposure time of 15 minutes is alternated every second day with the KL-VLOK-365 laser head for UV blood exposure with a wavelength of 365 nm, light guide tip power of 1.0 mW and exposure time of 5 minutes. If observing the third degree of activity, IL-1β of 2.01±0.18 pg/ml and more, IL-6 of 3.01±0.38 pg/ml and more, TNF-α of 3.3±0.25 pg/ml and more, IL-4 of 1.3±0.24 pg/ml and less, leptine of 8.8±0.72 pg/ml and more, glycosaminoglycans of 1.3±0.54 g/l, 10 daily procedures are performed. The KL-VLOK radiation head with a wavelength of 635 nm, disposable light guide tip power of 1.5-2.0 mW, exposure time of 15 minutes is alternated every second day with the KL-VLOK-365 laser head for UV blood exposure with a wavelength of 365 nm, light guide tip power of 1.0 mW and exposure time of 5 minutes. |
|
|
Invention refers to medicine, namely to therapeutic dentistry, and can be used for the local treatment of chronic gingivitis caused by tobacco smoking in young individuals. That is ensured by a preparatory procedure of luminal-dependent chemiluminescence of the oral fluid aiming at a maximum burst and a glow light sum. If the maximum burst falls within the range of 3.3 to 18.15 standard units, whereas the glow light sum ranges from 8.2 to 40 standard units, an antioxidant therapy is conducted by using a transverse gingival mucosa electrophoresis on 5% aqueous propolis by means of jaw electrodes in a tray at a current intensity of 0.5-1 mA and an exposure of 8-10 minutes. A polarity is alternated with a positive pole to be taken the first. The therapeutic course makes 4 procedures every second day. Colgate Propolis Toothpase and Mouthwash are used additionally during 30 days. If the maximum burst is from 0.8 to 1.24 standard units, whereas the glow light sum ranges from 3.34 to 7.5 standard units, a pro-oxidant therapy is required by using an exposure to magnetic infrared laser (MIL) light covering a projection of gums and generated by Optodan laser with a periodontal attachment The exposure parameters: 2-2,000 Hz in segments, 2 minutes per each segment, no more than 12 minutes per 1 procedure. The therapeutic course makes 4 procedures every second day. Parodontax Toothpase and Mouthwash are used additionally during 12 days. |
|
|
Method of treating amblyopia in children Invention refers to medicine, particularly to ophthalmology, and can be used in treating amblyopia in children. One 10-minute procedure involves alternating 1-2-minute exposure to green-range laser speckle structures at wavelength 0.5-0.65 mcm and red-range laser speckle structures at wavelength 0.63-0.7 mcm. Laser fluence is (4-8)×10-5 W/cm2. That is combined with autoscan exposure to a travelling magnetic field from temporal lobes to an occipital region by bitemporal method at a scan frequency of 90-180 Hz. A field density is 30-45 mT. The procedures are daily for 10 days. |
|
|
Method of treating periodontal diseases Implementing the presented method involves mixing gel Hyaludent 1 ml on a slide with Betaleukin 0.0005 ml dissolved in water for injections 1 ml; the produced content is applied with a single application syringe on a desalivated treated area of the involved periodontal tissues and left until completely absorbed for 1-3 minutes; the involved area is exposed to laser light generated by the laser semiconductor dental therapeutic apparatus Optodan with a periodontal tip in the mode II, with the exposure length for 3-5 minutes; the therapeutic course is 8 days daily. |
|
Method of treating gastric or duodenal ulcer in heavy smokers Method involves the fasting oral administration of placenta hydrolysate 2ml in water 200 ml at a temperature of 37°C in the morning. After that, the patient is laid down on his/her back and exposed to infrared laser light generated by the laser scanning physiotherapeutic simulator SLSF-03.2 IK. An initial end face output power is 2 mW at a power flow density of 50 mW/cm2 on a projection of an ulcer defect on frame No. 57 or No. 59 with laser light modulation at a frequency of 12-15 a second for 3 minutes per one field. That is followed by exposing a projection of a bend of the elbow on frame No. 30 or No. 40 for 10 minutes per a field. Further, the patient stays in the same position to perform transcranial electric stimulation generated by the Doctor TES-03 apparatus. A gel forehead electrode (+) is applied in the middle of the forehead skin until adhered to the skin uniformly. Two gel postaural electrodes are applied on bony mastoid processes (-) until adhered to the skin uniformly. The electrodes are fixed with a headband. The exposure has a current intensity of 1.5 mA in the form of a bipolar pulsing frequency of 77.5 Hz for 20 minutes. The therapeutic course makes 10 daily procedures. |
|
Method for endovascular laser coagulation of varicose great saphenous vein First stage involves the antegrade palpation-assisted insertion of a heavy-ended phlebextractor through an incision at the medial malleolus to straighten varicose segments. The phlebextractor is removed thereafter from the incision at the medial malleolus. Tumescence anaesthesia is applied along the vein trunk. That is followed by the coagulation of an inconsistent tibial segment of the great saphenous vein with the use of a laser light guide. The laser light guide is removed from the incision at the medial malleolus. A cosmetic stitch is applied on the wound. At the second stage: the heavy-ended phlebextractor is inserted palpation-assisted in the retrograde direction through a cross-ectomy incision to straighten varicose segments. The heavy-ended phlebextractor is used to remove any inconsistent valves, and an aiming beam controlled laser light guide is delivered along the phlebextractor. Thereafter, the phlebextractor is taken out of the cross-ectomy incision. Tumescence anaesthesia is applied. That is followed by the laser coagulation of an inconsistent femoral segment of the vein. The laser light guide is taken out of the cross-ectomy incision. The great saphenous vein stump is ligatured. The wound is closed. The whole surgical procedure is continuously ultrasound-controlled. |
|
Method of treating patients with rheumatoid arthritis As medications administered are: methotrexate 15 mg per week intake, folic acid 5 mg per week intake, movalis 15 mg per day intake. Laser therapy is administered in differential way depending on degree of disease activity and level of glucosaminoglycanes (GAG). In case of second stage of rheumatoid arthritis - index DAS28 3.2-5.1, level of glucosaminoglycanes 0.510±0.032 g/l, 7 daily procedures of intravenous laser irradiation are carried out. Radiating head KL-VLOK with wavelength 635 nm, power at the end of disposable light guide 1.5 mW, exposure time 15 minutes and laser head KL-VLOK-365 with wavelength 365 nm, power at the end of light guide 1.0 mW, exposure time 5 minutes, are alternated. In case of third degree of activity index DAS28 is higher than 5.1, GAG level is equal or is higher than 0.618±0.069 g/l, 10 procedures are carried out Radiating head KL-VLOK with wavelength 635 nm, power at outlet of disposable light guide 1.5-2.0 mW, exposure time 15 minutes and laser head KL-VLOK-365 nm, power at outlet of disposable light guide 1.0 mW, time of exposure 5 minutes. |
|
|
Group of inventions relates to medicine, namely to dermatology and mycology, and can be applied in the treatment of skin and its appendages. A pharmaceutical composition for external application contains nanoparticles for the laser thermotherapy of infectious affections of the skin and its appendages. The nanoparticles are characterised by, at least, one localised surface Plasmon resonance in the range of a wavelength from 400 to 1100 nm. The nanoparticles are dispersed in a physiologically acceptable carrier, which is characterised by the absence of the absorption or weak absorption and/or weak dispersion of light radiation in the said range of wavelengths and possessing biocidal properties. The pharmaceutical composition is applied on an affected area and irradiated by laser radiation with a wavelength close to the wavelength of the localised surface Plasmon resonance of the nanoparticles, contained in the composition, or equal to it. The irradiation is continued until the desirable temperature of heating of the said area is achieved. |
|
Method for hybrid phacoemulsification in narrow rigid pupil and iris-lens synechias Nucleus of lens is fragmented completely by femtosecond laser light at power 7,000-8,500 nJ; that is followed by making a corneal flap incision, dilating the pupil mechanically, and separating the synechias. A continuous circular capsulorhexis is performed, and the fragmented crystalline substance is emulsified. If observing degree II nuclear density, the nucleus is fragmented on 8 segments, while degrees III and IV requires fragmenting the nucleus on 8 segments in a combination with the circular incision in the centre 3 mm in diameter. |
|
|
Method for surgical management of clinical outcome of retinal venous thrombosis Method involves performing a vitrectomy with removing a posterior hyaloids of a vitreous body, and a laser retinal endocoagulation at wave length 532 nm, emitting power 120-200 mWt, pulse length 0.1-0.2 s, spot diameter 150-200 mcm. A chorioretinal venous anastomosis (CRVA) is induced by exposing the branches of the central vein of the retina to the third-order laser light at wave length 532 nm in a number of 4 coagulated, emitting power 500 mWt, pulse length 1 sec and spot diameter 50 mcm. The vitrectomy is preceded by the intramuscular injections of 12.5% etamylate 4ml and the intravenous administration of 0.5% tranexamic acid 1 g 25-30 minutes before. That is followed by the droplet intravenous administration of an infusion solution containing 0.1% perlinganit 10 ml in 0.9% normal saline 100 ml at an initial rate of 5 mcg/min. The area to be exposed to laser is specified at least in 3 diameters of the disk from the optic disk. The third-order laser applications are applied on the branches of the central vein of the retina in a number from 2 to 4 at wave length 532 nm, emitting power 300-400 mWt, exposure 0.5 s, spot diameter 500 mcm in two points in the proximal and distal direction from the CRVA induction point. Immediately before the CRVA induction, a salt-water infusion flow is increased until the central retinal artery starts pulsating. The surgical management is completed by plugging the vitreal cavity with 20% air-gas mixture SF6. |
|
|
Method for surgical management of chronic periodontitis Method involves professional oral hygiene is carried out consisting in ultrasonic removal of supra- and subgingival dental deposits and polishing of supragingival teeth. Bite splinting and recovery of dentition integrity may be required. After dissecting a mucoperiosteal flap according to the known technique, an incision area is sanitated by means of a photodynamic therapy (PDT). The PDT is conducted with the use of a diode laser at wave length 660±5 nm and emitting power 0.5-1.0 Wt. The photosensitiser "Photoditasin" in the form of 0.5% gel is introduced by means of a cannula into dental gaps, under the dissected segments of the flap and onto the mucosal tissue for 5 minutes. The photosensitiser is washed out, and the gingival pockets are repeatedly exposed to laser light for 2-3 min in the same environment. Sterile osteoplastic material is introduced into bone defects, and the flap is sutured together. |
|
|
Method of prevention of mastitis in cows In down-calving cows the entire mammary gland is irradiated with the contact method with scanning using laser beam with a wavelength of 0.63 microns. The low-intensity laser emitter power is 30 mW. The procedure is carried out for five minutes and is repeated five times with an interval of 48 hours. |
|
Method for face and neck skin rejuvenation Invention refers to medicine, namely to physiotherapy, dermatology and cosmetology, and can be used in stimulating regenerative processes in the face and/or neck skin. That is ensured by performing three stages, first two of which involve preparing to the third one. The first stage involves blood sampling from the patient, recovering the blood plasma, and enriching it with thrombocytes; the purified and enriched plasma is administered intradermally under the skin. Two days later, the second stage follows that involves the subcutaneous injections of hyaluronic acid. The third stage is performed 2-3 days later to expose different skin layers to laser light passing through different face and/or neck sections two to five times for one procedure. Passing once involves the alternating short-wave and long-wave laser exposure at a wave length of 1564-2940 nm. The procedure is repeated every 3-5 days with an increasing laser beam pulse energy from 35 mJ to 65 mJ. |
|
|
Method of photodynamic therapy Introduction of a photosensitiser and exposure to low intensive laser irradiation are realised. After carrying out photodynamic therapy (PDT) spectral-fluorescent diagnostics is performed and a degree of the medication burning out is determined. If the ratio of the tumour/norm is higher than 1.0, the absence of burning out is diagnosed. If the ratio of the tumour/norm is 0.8-1.0, partial burning out is diagnosed. If the ratio of the tumour/norm is lower than 0.8, complete burning out is diagnosed. In case of partial burning out or the absence of burning out PDT procedure is continued additionally with the power density of 0.35 W/cm2 by a step-by-step supply of 50 J/cm2 with the evaluation of a degree of burning out after each step. When complete burning out is registered, PDT procedure is finished. |
|
|
Method for conservative therapy of stress incontinence by er: yag-laser YAG laser is used. Each 4-6mm of the vagina is exposed sequentially circularly to four SMOOTH pulses. A handpiece output spot size is 7 mm; a frequency is 1.6 Hz; an energy flow density is 10 J/cm2. The exposure is generated by a full-scale handpiece and a circular adapter passing through three times to cover all the surfaces. Each 4-6mm of the vagina is exposed sequentially in a staggered order with the use of a fraction handpiece and an elbow adapter. The SMOOTH mode parameters: a handpiece output spot of 7 mm; a frequency of 1.6 Hz; an energy flow density of 10 J/cm2. A vaginal vestibule is exposed. |
|
Method of resort treatment of vegetovascular dystonia in workers of dangerous chemical enterprise Method includes taking radon bath with radon concentration 1.5 kBq (40 nCu/l), temperature 36-37°C, 10-15 minute duration. Source includes 10 procedures. Patient is given a session of listening to relaxing music 40 minutes after taking radon bath. After that, 5 symmetrical scalp zones are exposed to laser radiation for 30-40 seconds. Impact is realised by wavelength 0.82 mcm, power 12 mW, in pulse mode, with frequency 50 Hz. Sessions are carried out daily. Course includes 10 procedures. |
|
Method of treating glial brain tumours of supratentorial localisation Invention relates to medicine, namely to neurosurgery, neurooncology, and can be used for the treatment of glial brain tumours of a supratentorial localisation. For this purpose photodithazine in a dose of 1 mg/kg of body weight is introduced to a patient 2 hours before the tumour ablation. After that, surgical access to the tumour is performed. The operation wound is illuminated by blue colour with a wavelength of 400 nm, and the tumour boundaries are determined by means of fluorescence of photodithazine, selectively accumulated in the tumour tissue. The tumour is ablated under control of the tumour luminescence in blue colour with the application of an operation microscope. After that, a flexible light guide from a radiation source with a wavelength of 662 nm and power of 2.0 W with a light dispersing nozzle is placed into the tumour bed and the perifocal zone of the tumour is irradiated. The dose of irradiation is determined by the disappearance of fluorescence. |
|
|
Method for managing postoperative patients after septoplasty Septoplasty is followed by postoperative stable-contact pulsed magnetic laser infrared exposure on the patient's skin at wavelength 890-904 nm, power 7 Wt, frequency 80 Hz for 1.5 minutes. The exposure covers four points successively two of which adjoin wings of nose, whereas the other two are found on the lateral nasal walls. The treatment is performed for 3 days daily, 1 procedure a day. After swabs are taken off from the nasal cavity, the procedure is added with endonasal low-intensity red laser exposure for another 3 days at wavelength 635 nm in a continuous mode of power 5 Wt for 1.5 minutes in each half of the nasal cavity. |
|
|
Method of treating chronic generalised periodontitis Method of treating chronic generalised periodontitis includes the influence on an affected area by the therapeutic diode laser "HELBO" 2075 F/Theralite" with photosensitase "HELBO Blue Photosensitizer", with the application after the laser influence on the periodontium affected area of an adhesive gingival bandage, to prepare which the antioxidant "Melaxen", kalanchoe sap, glycosamine hydrochloride, dimethylsulphoxide, water dentine and solcoseryl dental adhesive paste are applied in specified quantities. |
|
Unit for photodynamic therapy of tumours of head and neck skin Unit for photodynamic therapy of tumours of head and neck skin contains the laser radiation source with the light guide which regulates a light dose and a plate (8) on a frontal holder (6). The fixture for protection of healthy skin from laser radiation is designed as three parallel flat disks (15, 16) and is fastened with a possibility of fixing in a standard position through the transitional device (11) on the frontal holder (6). Disks (15, 16) have a common central axis. External disks (15) are rigidly connected to each other along the perimeter forming a blind cavity connected to the transitional device (11). The internal disk (16) is designed with smaller diameter compared external disks (15), fixed on the common central axis with a possibility of rotation and divided into equal sectors. In each sector the individual through hole (18) of pre-set diameter is made. The centres of holes are located from a rotation axis at a minimum allowable distance. In each external disk (15) there is a coaxial hole designed as a sector the central angle of which is equal to the central angle of the internal disk sector. The transitional device (11) is designed as metal parallel plates (12). Plates (12) have a shape of an equilateral triangle with depressions in their tops. In one of tops the hinge (9) of the metal rod connected with the plate (8) of the frontal holder (6) is fixed, in the second top - the hinge of the metal rod (10) connected with the adaptation for protection of healthy skin from laser radiation, and in the third top - the hinge of an additional metal rod (5) on which clamps (4) for fixing of the laser light guide are rigidly fixed. One clamp (4) is fixed on an additional metal rod (5) in such a way that the axis of rotation of lips of this clamp is at the level of hole sector top in external disks, and the axis of rotation of lips of another clamp (4) is located from the axis of rotation of lips of the first clip (4) at the distance equal to the radius (R) of the sector hole in external disks (15). |
|
Method of treating early manifestations of age-related macular retinal degeneration Transcranial influence by a travelling pulse magnetic field with the induction of 35 mT, inversion frequency from 1 to 16 Hz, reversion time of 1 minute, is carried out. Then the eye is exposed to laser radiation with a wavelength of 0.633 mcm, in a mode of continuous radiation with the outlet power of 2.4 mW. On the first day the exposure to the magnetic field lasts 5 minutes, to the laser radiation - 1 minute. On the second day the exposure lasts 6 and 2 minutes, respectively. On the third day it lasts 7 and 3 minutes, respectively. From 4 to 10 day the exposure lasts 8 and 4 minutes, respectively. The influence is realised on each eye alternately. |
|
Method of treating proximal humeral injuries Invention refers to medicine, namely to traumatology and orthopaedics, and can be used for treating proximal humeral injuries. That is ensured by three-staged complex therapeutic actions. At the first stage, setting of fracture and reduction of humeral head dislocation is followed by immobilising an extremity by continuous twenty-four hour brace fixation of the proximal humerus with Desault's bandage for the period of 4 weeks. From the first therapeutic day, the patient does daily 30-minute therapeutic exercises, including isometric, static and ideomotor exercises to strengthen his/her arm muscles and to improve the circulation. That is combined with a complex reparative drug therapy. At the first stage, the anti-inflammatory preparation Arthrofoon is administered orally, while vasodilators improving nicotinic acid, trental or complamin microcirculation are injected intramuscularly daily for 10 days. The enzymatic preparations Wobenzyme or Flogenzyme are also administered in a dose of 3 tablets three times a day for 3-4 weeks. The second stage starting two weeks after the beginning of the treatment involves electric stimulation (ES) by exposing the collar and shoulder muscles from the involved side for 30 minutes to electric signals generated by an electric myostimulation device. The ES procedure requires the patient to perform 15-minute active motions by a healthy arm, and for the following 15 minutes the patient is expected to tense and relax alternatively the muscles from involved side. The therapeutic exercises are also done. The drug treatment regimen of the second stage implies administering the preparations Calcemin or Calcemin Advance for six months. That is combined with 10 daily intramuscular injections of the preparation Milgamma 2 ml. At the third stage 4 weeks after the beginning of the treatment, control X-ray imaging is followed by removing the brace. Accompanied by the reparative drug therapy continued, the complex therapeutic actions provide local injection therapy in number of 8-10 daily procedures. The biologically active reflex areas nearby the involved joint are pre-exposed to focused red laser light, and the mixed preparations Alflutop, or other chondroprotector, vitamin B12, Contrykal or Lidase, Lidocaine are injected in the same areas. Two weeks after the brace has been taken off, the patient keeps doing the therapeutic exercises twice a week continuously. The drug therapy and local injections are repeated six months later. The brace is further required for the following year if the patient is supposed to bear occupational or sports physical loads. |
|
Method of treating posterior uveitis Invention relates to medicine, namely to ophthalmology, and can be applied for the treatment of posterior uveitis. For this purpose sclerocompression, during which extreme parts of the eye bottom periphery near the toothed line of the retina are visualised through the eyelids, is created under conditions of drug mydriasis under ophthalmological control. Then laser-coagulation is performed by a contactless method. Coagulants are applied on the extreme periphery of the eye bottom, immediately in the zone of inflammation and on the boundary with healthy tissues. The diameter of the spot constitutes 100-350 mcm, with power of 400-1000 mW, impulse exposure of 0.1-0.3 sec. The general number of coagulants is 300 - 360. |
Another patent 2551194.